Previous 10 | Next 10 |
Jeffs’ Brands has entered into a non-binding letter of intent for, among others, the integration of the AI-based tool developed by B24Chat which will strengthen Jeffs' Brands' in-house marketing system and upgrade its marketing and services performance Tel Aviv, Israel, July 07...
2023-06-12 08:13:25 ET Forza X1 ( FRZA ) -21% . Sientra ( SIEN ) -17% . Baosheng Media Group ( BAOS ) -11% . Blue Apron ( APRN ) -11% . MGO Global ( MGOL ) -10% . Medigus ( MDGS ) -8% . Nasdaq ( NDAQ ) -8% on ...
2023-06-09 08:44:16 ET Sientra ( SIEN ) +82% stock rockets ~75% after hours on FDA approval for tissue expander. ContraFect ( CFRX ) +31% Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens a...
2023-06-09 08:44:16 ET Sientra ( SIEN ) +82% stock rockets ~75% after hours on FDA approval for tissue expander. ContraFect ( CFRX ) +31% Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens a...
2023-06-08 10:04:22 ET Gainers: Aclarion ( ACON ) +35% . Bone Biologics ( BBLG ) +17% . Atara Biotherapeutics ( ATRA ) +16% . Medigus ( MDGS ) +15% . AVITA Medical ( RCEL ) +13% . Losers: Panbela Therapeutics ( PBLA ) ...
2023-06-06 10:06:07 ET Medigus ( NASDAQ: MDGS ) said Tuesday it sold its entire stake in ScoutCam ( OTCPK:SCTC ), a provider of predictive maintenance and condition based monitoring visualization solutions, for ~$6M in cash. The buyers were ScoutCam's ( OTCPK:SC...
Tel Aviv, Israel, June 06, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, today announced that it has sol...
2023-05-16 18:07:15 ET Medigus ( NASDAQ: MDGS ) has filed for a $30M mixed shelf securities offering. The filing does not necessarily indicate that a sale has begun or will occur in the future. Shares are down ~8% in after-hours trading Tuesday. The medical technol...
2023-05-16 08:56:12 ET Medigus press release ( NASDAQ: MDGS ): Q1 EBITDA OF $658K Revenue of $20.9M (+2.5% Y/Y). For further details see: Medigus reports Q1 results
Viewbix , together with its subsidiaries, reached EBITDA of $658 thousand Tel Aviv, Israel, May 16, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging so...
News, Short Squeeze, Breakout and More Instantly...
Medigus Ltd. Company Name:
MDGS Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...
Medigus’ Nasdaq trading symbol will change to XYLO on April 18, 2024 Tel Aviv, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (“Medigus” or the “Company”), a technology-based company engaged in advanced innovative technologies, ...
Tel Aviv, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology-based company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, is excited to announce a landmark achievement by its subsidiary, Cha...